Ology Bio is a biologics CDMO specializing in single use processes up to BSL-3. Though having fairly extensive previous SBIR involvement, the last SBIR dollars we awarded in 2015. In April 2021 it was announced that the curently named firm had been acquired by a much smaller firm out of La Jolla CAm(dba Resilience) providing end-to-end biopharmaceutical manufacturing and development solutions and having already raised some $800M. _____________ Previous history: In April 2017, Nanotherapeutics - a specialty biopharmaceutical company with full product development, cGMP manufacturing capabilities, and a proprietary pipeline - was acquired by Serum Institute of India Pvt. Ltd. Formerly dba Nanosphere, Inc. Nanotherapeutics, Inc. is was renamed as Ology Bioservices in Oct 2017. The firm functions as a biopharmaceutical company specializing in the pre-clinical and clinical development, formulation, clinical trial management, and cGMP manufacturing of a pipeline of pharmaceutical products and medical devices. With major focus on developing a diversified proprietary pipeline of products having both biodefense and medical applications. products under development include biodefense, CNS, wound healing, addiction and pain, oncology, anti-infectives and orthopedics. At various point after 2009 and before its own acqusiiton, the firm was active in acquiring the assets of other small firms in trouble and/or closing up shop.
